News

News

January 7, 2021
AnaptysBio to Present at the 39th Annual J.P. Morgan Healthcare Conference
SAN DIEGO , Jan. 07, 2021 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced that